Výsledky vyhledávání - "R. C. Maranhão"

Akademický článek

Long term steroid metabolism balance studies in subjects on cholesterol-free and cholesterol-rich diets: comparison between normal and hypercholesterolemic individuals

Autor: R C Maranhão, E C Quintão

Publikováno v: Journal of Lipid Research, Vol 24, Iss 2, Pp 167-173 (1983)

Regulation of cholesterol metabolism was investigated in eight hypercholesterolemic and five normal individuals by combined intravenous pulse-labeling with radioactive cholesterol and fecal steroids balance techniques. Mean serum cholesterol concentr

Externí odkaz: https://doaj.org/article/11e2cf9c13e94b81bd49636b8759296f

Zobrazit plný text záznamu

Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma

Autor: S R R, Lucas, R C, Maranhão, J L, Guerra, B M P, Coelho, R, Barboza, D H B, Pozzi

Publikováno v: Veterinary and comparative oncology. 13(3)

A lipid nanoemulsion (LDE) resembling low-density lipoprotein can target malignant tumours. In in vivo and clinical studies, association of chemotherapeutic agents to LDE decreased their toxicity and increased pharmacological action. Here, safety of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2ca3964c13d2e260981e16666a6b2c48
https://pubmed.ncbi.nlm.nih.gov/23615221

Zobrazit plný text záznamu

Chylomicron metabolism is markedly altered in systemic lupus erythematosus

Autor: E F, Borba, E, Bonfá, C G, Vinagre, J A, Ramires, R C, Maranhão

Publikováno v: Arthritis and rheumatism. 43(5)

To verify the in vivo status of chylomicron metabolism in systemic lupus erythematosus (SLE) since there is a high incidence of atherosclerosis in this disease and chylomicrons may have an important role in atherogenesis.A chylomicron-like emulsion l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7873b7d3bd081e6baf4ef0cedf0c7507
https://pubmed.ncbi.nlm.nih.gov/10817556

Zobrazit plný text záznamu

Chylomicron metabolism in patients submitted to cardiac transplantation

Autor: C G, Vinagre, N A, Stolf, E, Bocchi, R C, Maranhão

Publikováno v: Transplantation. 69(4)

Development of coronary graft disease is the most important cause of late heart graft failure. Alterations in plasma lipid profile are frequent in heart transplant (HT) patients, but they seem not to be prominent. Currently, the metabolism of chylomi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da169c560b17ad580ee1b514a74a1e96
https://pubmed.ncbi.nlm.nih.gov/10708107

Zobrazit plný text záznamu

[Comparison of hypercholesterolemic men and women at high risk for atherosclerosis. Study of risk factors and response to pravastatin treatment]

Autor: R D, Santos, R C, Maranhão

Publikováno v: Arquivos brasileiros de cardiologia. 70(6)

To compare the prevalence of risk factors, and the response to pravastatin treatment between men and women.We evaluated 486 men and 386 women, of these 230 men and 187 women received 10 mg of pravastatin for three months.There were differences betwee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eeec06c6ab5c06772926950e3d47fe81
https://pubmed.ncbi.nlm.nih.gov/9713078

Zobrazit plný text záznamu

[Assessment of short-term effects of awareness programs and pravastatin therapy on subjects from private clinics at high risk for cardiovascular disease]

Autor: R D, Santos, L O, do Nascimento, R C, Maranhão e Pesquisadores

Publikováno v: Arquivos brasileiros de cardiologia. 69(4)

To evaluate short-term efficacy of awareness programs (AP) in reducing coronary heart disease risk factors (CHDRF).High risk hypercholesterolemic patients were divided in 2 groups during 16 weeks. Group A (n = 417, 54.3 +/- 10.0 years, 55% males) rec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b7b53b8c5e853e836ffb575afe02136
https://pubmed.ncbi.nlm.nih.gov/9595713

Zobrazit plný text záznamu

[Comparative study of gemfibrozil versus pravastatin in the treatment of patients with coronary artery disease and low HDL cholesterol levels]

Autor: R D, Santos, A P, Mansur, J, Safi Júnior, R R, Giraldez, R C, Maranhão, F, Pileggi, J A, Ramires

Publikováno v: Arquivos brasileiros de cardiologia. 65(2)

To evaluate the effects of gemfibrozil and pravastatin in coronary artery disease patients with HDL-cholesterol (HDL-C)35 mg/dl).Twenty-nine patients (20 males, 60 +/- 9) were divided in a gemfibrozil group (G) (1200 mg/day n = 15) and a pravastatin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::08a4fcaca73b756af29a0ad36a7ea14b
https://pubmed.ncbi.nlm.nih.gov/8554498

Zobrazit plný text záznamu

Lipoprotein (a) in subjects with or without coronary artery disease: relation to clinical history and risk factors

Autor: R C, Maranhão, C G, Vinagre, S, Arie, J B, Guimarães, P, da-Luz, G, Bellotti, F, Pileggi

Publikováno v: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 28(4)

Lipoprotein (a) [Lp(a)] is an atherogenic lipoprotein resembling low-density lipoprotein (LDL) but with an additional apoprotein (apo), apo(a). To determine whether plasma Lp(a) levels can influence the clinical presentation and extent of coronary ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0a9f863a6cc58c1992f28755464f7769
https://pubmed.ncbi.nlm.nih.gov/8520541

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání